Why generic EMRs struggle with IVF workflows

Table of Contents

• Introduction
• Why the Right Software Matters for IVF Workflows
• The Core Challenge of Using a Generic EMR for IVF
• Impact of Generic EMR Limitations on IVF Clinic Operations
• The IVF Workflow Features That Generic EMRs Cannot Provide
• Deep Dive: How Generic EMRs Break Down Across the IVF Cycle
• Strategies for Working Around Generic EMR Limitations
• What a Purpose-Built IVF System Provides Instead
• Compliance and Reporting Consequences of Using a Generic EMR
• Planning a Move Away From a Generic EMR
• Keeping Data Quality Stable During and After the Transition
• Overview of Generic EMR Gaps and Their Consequences
• FAQs
• Conclusion

Introduction

Generic electronic medical record systems are built to handle a wide range of clinical settings. They manage appointments, store clinical notes, issue prescriptions, and record diagnoses across many different types of medical practice. For most specialties, this breadth is an advantage. A tool that works across many settings is easier to procure, easier to support, and easier to integrate into a broader health system.

IVF is an exception. The workflows involved in an assisted reproduction treatment cycle are so specific, so sequential, and so dependent on specialised data structures that a generic EMR cannot support them without significant compromise. Clinics that try to manage their IVF workflows through a general-purpose system end up building workarounds on top of workarounds, absorbing hidden costs in staff time and data quality that rarely get counted up in full.

This guide looks at exactly why generic EMRs struggle with IVF workflows, what that struggle costs in practice, and what fertility clinics can do to address it.

Why the Right Software Matters for IVF Workflows?

An IVF treatment cycle is not a single clinical event. It is a sequence of tightly connected stages, each producing data that directly informs the next. The stimulation phase produces monitoring data that determines when egg collection happens. The egg collection produces laboratory data that drives the embryology phase. The embryology phase produces development and grading data that determines what is transferred and what is stored. Each stage depends on what came before it, and the data from each stage needs to be linked clearly to the same cycle record throughout.

• Supports clinical decision-making at every stage of the cycle with structured data from previous stages
• Keeps laboratory and clinical teams working from the same up-to-date record without manual synchronisation
• Enables accurate cryopreservation tracking linked directly to the patient and cycle that produced the stored material
• Produces the structured data outputs required for national registry reporting without manual reformatting
• Reduces the administrative burden on staff by guiding them through IVF-specific workflows rather than requiring them to adapt general clinical tools

When the software a clinic uses cannot support these requirements natively, the clinical team fills the gaps through effort and ingenuity. That effort has a cost, and the gaps it is filling create risks that a well-designed system would remove entirely.

The Core Challenge of Using a Generic EMR for IVF

The main challenge for fertility clinic software teams is that a generic EMR is built around a flat patient record model. It stores information about a patient as a collection of appointments, notes, and documents linked to a single individual. It does not have a built-in concept of a treatment cycle as an organising unit that groups a sequence of clinical and laboratory events together and maintains the relationships between them.

This structural difference matters enormously in an IVF context. When a clinic tries to record an IVF cycle in a generic EMR, the data from the stimulation phase, the egg collection, the laboratory, and the transfer all end up stored as separate notes, appointments, or documents rather than as connected parts of a single cycle record. The connections between them have to be maintained by staff rather than by the system, and they are maintained inconsistently.

The challenge is not that generic EMR systems are badly made. It is that they were designed to solve a different problem. Using one to manage IVF workflows is not a configuration issue that can be fixed with the right settings. It is a structural mismatch that no amount of customisation fully resolves.

Impact of Generic EMR Limitations on IVF Clinic Operations

When a fertility clinic runs its IVF workflows through a generic EMR that cannot properly support them, the operational consequences appear across every part of the clinic:

• Clinicians reviewing a patient’s record before a consultation have to piece together the treatment history from multiple notes, attachments, and appointment entries rather than seeing a structured cycle summary
• Laboratory teams track embryo development and cryopreservation inventories in systems or spreadsheets that exist outside the main EMR because the main system has nowhere to put this data properly
• Administrative staff spend significant time manually preparing data for national registry submissions because the EMR does not produce the required output format automatically
• New staff take longer to become productive because the workarounds and conventions built up around the generic system are not intuitive and are rarely fully documented
• Data quality problems accumulate in free-text fields and unstructured notes that cannot be validated, searched, or reported on reliably

Each of these impacts is manageable on its own. Together, they represent a significant ongoing drag on the quality and efficiency of clinical operations that grows worse as the clinic’s patient volume increases.

The IVF Workflow Features That Generic EMRs Cannot Provide

There are specific functional requirements that IVF workflows demand and that generic EMRs consistently fail to provide. Understanding these gaps helps clinics assess the real cost of their current system and build the case for change.

• Cycle-level record structure that groups all clinical, laboratory, and outcome events for a single treatment episode into one linked and navigable record
• Structured embryology data fields for oocyte maturity, fertilisation, cleavage stage, blastocyst grading, and biopsy outcomes linked to individual embryos within a specific cycle
• Sequential stimulation monitoring capture that stores daily scan measurements and hormone values as a time series linked to the active cycle rather than as individual unconnected entries
• Integrated cryopreservation inventory management that tracks stored embryos and gametes with storage location, consent status, and expiry information linked directly to the patient record
• Donor programme record structures that maintain the required clinical linkages between donor and recipient records while enforcing the privacy controls that fertility regulations require
• Pre-configured reporting outputs for national fertility registries in the specific formats those registries require

None of these requirements are unusual or unreasonable. They are the basic operational needs of any clinic running IVF treatment at scale. The fact that generic EMRs cannot meet them is not a failure of those systems. It is simply a reflection of the fact that they were designed for a broader and less specialised use case.

Deep Dive: How Generic EMRs Break Down Across the IVF Cycle

The breakdown of a generic EMR in an IVF context does not happen all at once. It happens stage by stage, as each phase of the cycle encounters a different aspect of the system’s structural limitations.

During the stimulation phase, the problem is sequential monitoring data. A generic EMR records each scan or blood result as a separate clinical entry linked to a date, not as a data point within a continuous stimulation series. Staff have to apply naming conventions or create custom note templates to make it clear which entries belong to the same cycle, and the system cannot automatically calculate or display the progression of monitoring values over time in the way that clinical decision-making requires.

During the laboratory phase, the problem is the complete absence of structured embryology fields. A generic EMR has no concept of an individual embryo as a record entity. Fertilisation outcomes, cleavage stage data, and blastocyst grades end up recorded in free-text notes or attached documents that cannot be searched, validated, or linked to a specific embryo that may later be transferred or stored. The laboratory team typically maintains a separate tracking system for this data, creating a split record that staff have to manually keep in sync.

At the transfer and outcome stage, the problem is the lack of ART-specific outcome classifications. A generic EMR uses diagnosis codes designed for general clinical practice. Recording a biochemical pregnancy, a clinical miscarriage, or a live birth with specific outcome attributes requires either repurposing codes in ways they were not designed for or storing the information in free text. Either approach produces outcome data that is inconsistent across patients and unusable for registry reporting without manual reclassification.

Strategies for Working Around Generic EMR Limitations

Clinics that are currently using a generic EMR and need to manage their IVF workflows within it can take steps to reduce the risks created by the system’s structural gaps while a longer-term solution is developed.

• Create and document standardised templates for recording IVF-specific data in the EMR’s note or form fields so that all staff use the same format and the data is at least internally consistent even if it cannot be validated automatically
• Implement a dedicated supplementary tool for embryology data and cryopreservation tracking, and define a clear and regularly reviewed synchronisation procedure between that tool and the main EMR record
• Assign explicit ownership for each section of the cycle record so that every data point has a named responsible role and gaps do not develop because each team member assumed someone else was responsible
• Run regular completeness checks across active cycle records to identify missing fields before the gaps affect clinical use or regulatory reporting
• Build the business case for a transition to specialist fertility software so that the move can be planned and resourced properly rather than being treated as a future problem

These strategies reduce the operational cost and data quality risk of using a generic EMR for IVF workflows. They do not eliminate it. They are practical short-term measures rather than a substitute for a system that fits the clinical context properly.

What a Purpose-Built IVF System Provides Instead

A purpose-built fertility software platform is designed from the ground up around the data model and workflow logic of IVF treatment. The cycle record is the central organising unit, and every clinical and laboratory event in a treatment episode is linked to it automatically rather than through manual convention.

Stimulation monitoring data is captured as a structured time series within the active cycle record, with built-in display tools that show the progression of follicle development and hormone levels over the stimulation phase in the format that clinicians actually use to make trigger and collection decisions. Staff do not need to create workarounds to present this data coherently because the system presents it coherently by default.

Embryology records are maintained at the level of the individual embryo, with structured fields for every development stage and a persistent history that follows each embryo through collection, culture, biopsy, grading, transfer, and storage across multiple cycles if necessary. Cryopreservation tracking is built into the same record structure rather than maintained separately, so the clinic’s embryo and gamete inventory is always current and always linked to the patients and cycles it belongs to.

Compliance and Reporting Consequences of Using a Generic EMR

The data quality problems that accumulate in a generic EMR used for IVF workflows have direct consequences for the clinic’s ability to meet its regulatory reporting obligations. National fertility registries require structured cycle data in defined formats. When that data is stored in free-text fields, repurposed code fields, and external spreadsheets, producing a compliant submission requires a substantial manual effort that introduces error risk and cannot be automated or audited reliably.

• Review the specific data fields required by each national registry the clinic reports to and assess which of those fields are currently held in structured form in the EMR and which require manual extraction or reformatting
• Calculate the staff time currently spent on manual data preparation for each submission cycle and include this as part of the total cost of using a generic EMR for IVF data management
• Conduct a pre-submission completeness check against all required registry fields before each submission to identify gaps that need to be addressed before the data is submitted
• Document the manual steps involved in current submission preparation so that the process can be audited if a submission is queried by the registry
• Use the compliance cost of current EMR limitations as evidence in the business case for transitioning to a system that produces registry-ready outputs automatically

Clinics that have received correction requests or compliance findings related to registry submissions should review whether the underlying cause was a data quality problem originating in the structural limitations of their current system rather than an isolated recording error. Recurring submission problems are often a symptom of a system mismatch rather than a training issue.

Planning a Move Away From a Generic EMR

Moving from a generic EMR to a purpose-built fertility platform is a significant project, but it is one that most fertility clinics running IVF at scale will eventually need to undertake. The longer the move is deferred, the more historical data accumulates in formats that will be harder to migrate, and the more embedded the workarounds become in the daily habits of the clinical team.

The planning process should start with a full inventory of every data source currently in use, including the main EMR, any supplementary tools or spreadsheets, and any external laboratory or imaging systems that feed data into the patient record. Each source needs a data mapping plan that defines how its contents will be translated into the structure of the new system and how gaps or inconsistencies in the current data will be handled during migration.

Vendor selection should prioritise platforms that have native support for all the ART-specific data types the clinic needs to manage and that have demonstrable experience of migrating data from the type of generic EMR the clinic is currently using. References from comparable clinics that have completed a similar transition are the most reliable evidence of a vendor’s ability to deliver.

Keeping Data Quality Stable During and After the Transition

The period immediately following a system transition is one of the highest-risk periods for data quality in a fertility clinic. Staff are working in an unfamiliar system, migrated historical data may contain inconsistencies that were not visible before migration, and integrations with external laboratory or imaging platforms may need time to stabilise.

Enhanced monitoring of data completeness and accuracy should be in place from the first day of go-live, not introduced after problems are reported. Completeness checks should run daily across all critical IVF data fields in the weeks immediately after transition, with results reviewed by a designated data quality lead who has the authority to escalate issues quickly. Any field that was problematic in the old system should receive particular attention in the new one to confirm that the structural improvement has translated into better data in practice.

Staff confidence and system familiarity grow significantly in the first three months after go-live. Regular short check-ins between the clinical team and the implementation lead during this period allow practical problems to be identified and resolved quickly before they become established habits. A system that fits the clinical workflow well will feel noticeably more natural to use than the workaround-dependent generic EMR it replaced, and that difference in user experience is one of the clearest signals that the transition has been a genuine improvement.

Overview of Generic EMR Gaps and Their Consequences

FAQs

Can a generic EMR be customised to work well for IVF?

Some degree of customisation is possible in most generic EMR platforms, including custom forms, additional data fields, and note templates. However, customisation cannot address the underlying structural limitations of a flat patient record model. It can make certain data easier to enter, but it cannot create a genuine cycle-level data structure, enforce IVF-specific validation logic, or produce ART registry outputs automatically. For clinics running IVF at significant volume, customisation of a generic system is a short-term improvement rather than a long-term solution.

How do fertility clinics typically manage embryology data when using a generic EMR?

The most common approach is to maintain a separate dedicated embryology system or spreadsheet alongside the main EMR, with a manual process for synchronising key data points between the two. This works well enough in the short term but creates ongoing risk from records falling out of sync and adds a recurring administrative burden that grows with patient volume.

At what point does it become necessary to move away from a generic EMR?

There is no single threshold, but the case for moving becomes compelling when the time spent on workarounds and manual data reconciliation is measurable, when data quality problems are affecting clinical decisions or regulatory submissions on a recurring basis, or when the clinic is growing and the volume of IVF activity is making the current approach increasingly unsustainable. Many clinics find that they have passed this point before they formally acknowledge it.

What is the most important thing to check when selecting a specialist fertility software platform?

The most important check is whether the platform has native structured data fields for every ART-specific data type the clinic needs to manage, not whether those fields can be created through customisation. A system that requires significant configuration to support IVF workflows is closer to a generic EMR with extra steps than to a purpose-built fertility platform. The clinical and laboratory teams who will use the system every day should be involved in the evaluation to confirm that the workflow logic matches their actual working practice.

How should a clinic handle data that was recorded in non-standard formats in the old EMR?

Data recorded in free-text fields or repurposed code fields in the old system should be reviewed and reclassified into the structured format of the new system as part of the migration process. This is time-consuming but necessary for the historical data to be usable in the new environment. Priority should be given to records for currently active patients. For older records where reclassification is not practical, the original data should be archived in a readable format and linked to the patient’s new system record so that it remains accessible if needed.

Conclusion

Generic EMRs struggle with IVF workflows because they lack the fertility-specific structure needed to manage complex clinical and laboratory processes. As a result, clinics rely on manual workarounds that consume staff time, reduce data accuracy, create operational inefficiencies, and increase the burden of maintaining compliant patient records every day.

IVF software is designed specifically for fertility clinics, supporting treatment cycles, laboratory workflows, patient timelines, and regulatory compliance in one platform. By replacing manual processes with automation, clinics improve efficiency, maintain reliable data, reduce administrative workload, and deliver higher-quality patient care throughout every stage of IVF treatment.